GlassScriptPhysician profile
Edward J Kowlowitz
NPI 1972590529
$15,300.09
in general payments reported to CMS, 2019-2025
44 companies · $1,557 in 2025
The $1,557 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,957 · 2020: $1,307 · 2021: $2,302 · 2022: $1,653 · 2023: $1,578 · 2024: $2,948 · 2025: $1,557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,082.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,082.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,371.41 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Abbott Laboratories | $2,414.99 | 2019-2025 | Proclaim |
| Vertiflex, INC. | $1,830.91 | 2019 | |
| Medtronic, INC. | $1,673.52 | 2021-2024 | Intellis Adaptivestim, Synchromedii, Vanta Adaptivestim |
| Vertos Medical, INC. | $903.59 | 2021-2024 | Mild Device Kit |
| Abbvie INC. | $695.26 | 2021-2025 | |
| Tersera Therapeutics LLC | $604.20 | 2019-2025 | Prialt |
| Biotronik Nro, INC. | $541.09 | 2023-2025 | Prospera, Biotronik |
| Amgen INC. | $415.10 | 2019-2022 | |
| Saluda Medical Americas, INC. | $387.62 | 2024-2025 | Evoke |
| Nevro Corp. | $242.66 | 2019 | |
| Mml US, INC. | $224.25 | 2024-2025 | Reactiv8 |
| Neuronetics, INC. | $157.45 | 2022 | |
| Biodelivery Sciences International, INC. | $152.97 | 2019-2021 | |
| Stryker Corporation | $149.81 | 2024 | Mild Device Kit |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Kowlowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.